Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial (Q28254919)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial |
scientific article |
Statements
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial (English)
Young-Hyuck Im
Laslo Roman
Ling-Ming Tseng
Mei-Ching Liu
Elżbieta Staroslawska
Juan de la Haba-Rodriguez
Jose Luiz Pedrini
Brigitte Poirier
Paolo Morandi
Vichien Srimuninnimit
Tania Szado
Jayantha Ratnayake
Graham Ross
Pinuccia Valagussa
6 December 2011
Identifiers
2 references
2 references